1. Home
  2. NTIP vs ICCM Comparison

NTIP vs ICCM Comparison

Compare NTIP & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTIP
  • ICCM
  • Stock Information
  • Founded
  • NTIP 1990
  • ICCM 2006
  • Country
  • NTIP United States
  • ICCM Israel
  • Employees
  • NTIP N/A
  • ICCM N/A
  • Industry
  • NTIP Multi-Sector Companies
  • ICCM
  • Sector
  • NTIP Miscellaneous
  • ICCM
  • Exchange
  • NTIP Nasdaq
  • ICCM Nasdaq
  • Market Cap
  • NTIP 37.5M
  • ICCM 36.0M
  • IPO Year
  • NTIP 1998
  • ICCM N/A
  • Fundamental
  • Price
  • NTIP $1.65
  • ICCM $0.82
  • Analyst Decision
  • NTIP
  • ICCM Strong Buy
  • Analyst Count
  • NTIP 0
  • ICCM 2
  • Target Price
  • NTIP N/A
  • ICCM $2.95
  • AVG Volume (30 Days)
  • NTIP 20.1K
  • ICCM 349.1K
  • Earning Date
  • NTIP 08-08-2024
  • ICCM 08-12-2024
  • Dividend Yield
  • NTIP 6.21%
  • ICCM N/A
  • EPS Growth
  • NTIP N/A
  • ICCM N/A
  • EPS
  • NTIP N/A
  • ICCM N/A
  • Revenue
  • NTIP $2,064,000.00
  • ICCM $3,262,000.00
  • Revenue This Year
  • NTIP N/A
  • ICCM $16.85
  • Revenue Next Year
  • NTIP N/A
  • ICCM $57.25
  • P/E Ratio
  • NTIP N/A
  • ICCM N/A
  • Revenue Growth
  • NTIP 284.36
  • ICCM 7.02
  • 52 Week Low
  • NTIP $1.52
  • ICCM $0.52
  • 52 Week High
  • NTIP $2.60
  • ICCM $1.57
  • Technical
  • Relative Strength Index (RSI)
  • NTIP 52.62
  • ICCM 55.57
  • Support Level
  • NTIP $1.56
  • ICCM $0.62
  • Resistance Level
  • NTIP $1.68
  • ICCM $0.78
  • Average True Range (ATR)
  • NTIP 0.07
  • ICCM 0.05
  • MACD
  • NTIP 0.01
  • ICCM 0.02
  • Stochastic Oscillator
  • NTIP 72.22
  • ICCM 90.91

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: